Capital Advisors Ltd’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$230K Sell
2,935
-296
-9% -$23.9K 0.02% 286
2026
Q1
$280K Sell
3,231
-35
-1% -$3.35K 0.03% 257
2025
Q4
$314K Sell
3,266
-2
-0.1% -$194 0.04% 233
2025
Q3
$311K Buy
3,268
+42
+1% +$3.86K 0.04% 231
2025
Q2
$281K Sell
3,226
-54
-2% -$4.58K 0.03% 234
2025
Q1
$295K Sell
3,280
-104
-3% -$9.31K 0.04% 226
2024
Q4
$270K Buy
3,384
+199
+6% +$17.2K 0.03% 234
2024
Q3
$287K Buy
3,185
+6
+0.2% +$505 0.04% 228
2024
Q2
$250K Sell
3,179
-16
-0.5% -$1.31K 0.03% 244
2024
Q1
$278K Buy
3,195
+71
+2% +$6.06K 0.04% 231
2023
Q4
$257K Buy
3,124
+54
+2% +$4.12K 0.04% 230
2023
Q3
$241K Sell
3,070
-21
-0.7% -$1.76K 0.04% 229
2023
Q2
$272K Buy
3,091
+1
+0% +$86 0.04% 221
2023
Q1
$249K Buy
3,090
+49
+2% +$3.99K 0.04% 203
2022
Q4
$236K Buy
3,041
+84
+3% +$6.81K 0.04% 209
2022
Q3
$239K Sell
2,957
-164
-5% -$14.7K 0.05% 204
2022
Q2
$280K Sell
3,121
-482
-13% -$48.8K 0.05% 182
2022
Q1
$400K Buy
3,603
+40
+1% +$4.23K 0.07% 161
2021
Q4
$369K Buy
3,563
+198
+6% +$22.9K 0.06% 170
2021
Q3
$422K Buy
+3,365
New +$436K 0.08% 131
2021
Q2
Sell
-2,828
Closed -$334K 484
2021
Q1
$334K Hold
2,828
0.06% 132
2020
Q4
$331K Hold
2,828
0.07% 126
2020
Q3
$294K Hold
2,828
0.07% 124
2020
Q2
$259K Hold
2,828
0.07% 133
2020
Q1
$255K Hold
2,828
0.08% 128
2019
Q4
$321K Hold
2,828
0.08% 109
2019
Q3
$307K Sell
2,828
-515
-15% -$53.7K 0.09% 110
2019
Q2
$326K Buy
3,343
+515
+18% +$47K 0.09% 108
2019
Q1
$258K Hold
2,828
0.07% 132
2018
Q4
$257K Hold
2,828
0.08% 128
2018
Q3
$278K Buy
+2,828
New +$261K 0.08% 124

Other funds holding MDT

Capital Advisors Ltd's MDT Position: Q2 2026 in Review

Capital Advisors Ltd reduced its Medtronic (MDT) stake by 9.2% in Q2 2026, selling an estimated $23.9K and leaving 2,935 shares worth $230K. The position accounts for 0.02% of the portfolio, ranked #286.

Capital Advisors Ltd first reported a position in MDT in Q3 2018 and has held it in 31 quarters since. The position peaked at $422K in Q3 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Capital Advisors Ltd held 2,935 shares of Medtronic worth $230K as of Q2 2026.
  • Capital Advisors Ltd sold 296 Medtronic shares in Q2 2026, an estimated $23.9K.
  • Medtronic made up 0.02% of Capital Advisors Ltd's portfolio in Q2 2026, its #286 holding.
  • Capital Advisors Ltd first reported a position in Medtronic in Q3 2018 and has held it in 31 quarters since.
  • Capital Advisors Ltd's Medtronic position peaked at $422K in Q3 2021.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.